Market Tracker

07/22 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.89
Data as of Jul 22
 -0.01 / -0.17%
Today’s Change
2.05
Today|||52-Week Range
8.25
+10.49%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close5.90
Today’s open5.97
Day’s range5.86 - 6.10
Volume779,120
Average volume (3 months)2,351,108
Market cap$610.1M
Dividend yield--
Data as of 3:59pm ET, 07/22/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+12.25%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc-0.56-2.05%
OREXOrexigen Therapeutic...-0.10-1.86%
NLNKNewLink Genetics Cor...+0.33+1.58%
OMEDOncoMed Pharmaceutic...+0.43+2.00%
Data as of 4:00pm ET, 07/22/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts